Preview

Medical Herald of the South of Russia

Advanced search

Autoimmune polyglandular syndrome type 1

https://doi.org/10.21886/2219-8075-2022-13-2-168-171

Abstract

Type 1 autoimmune polyglandular syndrome (APS1) is a rare disease, with an unknown prevalence in the Russian population. Due to the low awareness of doctors, it takes more time to make the accurate diagnosis and provide correct medical care. This article describes classical features of APS1 and a clinical case of a patient, who did not have one of the most common first manifestation of the disease - mucocutaneous candidiasis. Hypocalcemia was detected much later than the first clinical manifestations in the form of generalized seizures occurred. Patient also suffers from tapetoretinal abiotrophy, he completely lost vision in childhood which made it difficult for the doctor and patient to interact in the treatment of the disease.

About the Authors

T. A. Kiseleva
Kazan State Medical University
Russian Federation

Tatiana A. Kiseleva, Cand. Sci. (Med.), associate professor of the Department of Endocrinology 

Kazan



F. V. Valeeva
Kazan State Medical University
Russian Federation

Farida V. Valeeva, Dr. Sci. (Med.), professor, the Head of the Department of Endocrinology 

Kazan



D. L. Ekimovskaya
Kazan State Medical University
Russian Federation

Dina L. Ekimovskaya, clinical resident of the Department of endocrinology 

Kazan



M. A. Makarov
Kazan State Medical University
Russian Federation

Maksim A. Makarov, PhD, associate professor of the Department of propaedeutics of internal diseases 

Kazan



R. T. Habibullina
City Hospital №11
Russian Federation

Ramziya T. Khabibullina, deputy medical director  

Kazan



References

1. Husebye ES, Anderson MS, Kämpe O. Autoimmune Polyendocrine Syndromes. N Engl J Med. 2018;378(12):1132- 1141. DOI: 10.1056/NEjMra1713301.

2. Bruserud Ø, Oftedal BE, wolff AB, Husebye ES. AIRE-mutations and autoimmune disease. Curr Opin Immunol. 2016;43:8-15. DOI: 10.1016/j.coi.2016.07.003.

3. Orlova EM, Sozaeva LS, Kareva MA, Oftedal BE, wolff ASB, et al. Expanding the Phenotypic and Genotypic Landscape of Autoimmune Polyendocrine Syndrome Type 1. J Clin Endocrinol Metab. 2017;102(9):3546-3556. DOI: 10.1210/jc.2017-00139.

4. Perheentupa j. Autoimmune polyendocrinopathy-candidiasisectodermal dystrophy. J Clin Endocrinol Metab. 2006;91(8):2843-50. DOI: 10.1210/jc.2005-2611.

5. Betterle C, Greggio NA, Volpato M. Clinical review 93: Autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab. 1998;83(4):1049-55. DOI: 10.1210/jcem.83.4.4682.

6. Breunig A, Lee MS, Miller BS, Binstadt BA, Anderson MS, Montezuma S. Autoimmune retinopathy in a patient with autoimmune polyendocrine syndrome type I. Ocul Immunol Inflamm. 2013;21(2):153-7. DOI: 10.3109/09273948.2012.754906.

7. Brännström j, Hässler S, Peltonen L, Herrmann B, winqvist O. Defect internalization and tyrosine kinase activation in Aire deficient antigen presenting cells exposed to Candida albicans antigens. Clin Immunol. 2006;121(3):265-73. DOI: 10.1016/j.clim.2006.08.005.


Review

For citations:


Kiseleva T.A., Valeeva F.V., Ekimovskaya D.L., Makarov M.A., Habibullina R.T. Autoimmune polyglandular syndrome type 1. Medical Herald of the South of Russia. 2022;13(2):168-171. (In Russ.) https://doi.org/10.21886/2219-8075-2022-13-2-168-171

Views: 1526


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2219-8075 (Print)
ISSN 2618-7876 (Online)